Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2025-12-25 @ 7:08 PM
Study NCT ID:
NCT03469804
Status:
UNKNOWN
Last Update Posted:
2019-10-21
First Post:
2018-03-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-09-20
Completion Date Type:
ESTIMATED
First Submit Date:
2018-03-12
First Submit QC Date:
None
Study First Post Date:
2018-03-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-18
Last Update Post Date:
2019-10-21
Last Update Post Date Type:
ACTUAL